Intraocular Lens Market Size To Expand at a Notable CAGR Of 5.17% During 2023 - 2030

Report Details:
15 Companies Covered
200 Pages

Growing Geriatric Population and Technological Advancements to Drive to USD 9.28 Billion by 2035


Market Research Future (MRFR) has published a cooked research report on the “Global Intraocular Lens Market” containing analysis from 2019 to 2035. The Global Intraocular Lens Market is projected to grow from USD 5.32 billion in 2025 to USD 9.28 billion by 2035, registering a CAGR of 5.72% during the forecast period (2025–2035). The market expansion is primarily driven by the increasing prevalence of cataracts, rising healthcare expenditure, and advancements in lens design technologies that improve post-surgical visual outcomes and patient satisfaction.


MRFR recognizes the following companies as the key players in the Global Intraocular Lens Market: Ophtec, Jiangsu Wunuo Medical Technology, Kowa Company, Carl Zeiss AG, HumanOptics AG, Bausch + Lomb, Johnson and Johnson, Abbott, Alcon, SIFI Medtech, STAAR Surgical, VSY Biotechnology, Rayner Surgical, and Hoya Corporation.


Market Highlights


The Global Intraocular Lens Market is experiencing robust growth due to the rising prevalence of cataracts, an aging global population, and technological innovations in lens materials and design. The market was valued at 5.03 USD Billion in 2024 and is projected to reach 9.28 USD Billion by 2035. Increasing awareness of cataract treatment options and enhanced accessibility to ophthalmic procedures are contributing significantly to market expansion. Healthcare expenditure in key regions such as North America and Europe, accounting for nearly 15% of GDP, supports the availability of advanced medical facilities and surgical technologies.


Demographic factors, including the rising geriatric population, have intensified the demand for cataract surgeries, thereby increasing the adoption of intraocular lenses. Technological advancements—such as multifocal and toric lenses—have improved visual outcomes, with up to 90% patient satisfaction reported post-surgery. Furthermore, initiatives by organizations such as the International Agency for the Prevention of Blindness are fostering greater awareness and encouraging individuals to pursue timely eye care interventions. The trend toward personalized medicine and minimally invasive procedures is further enhancing the market’s growth outlook, supported by the continuous evolution of surgical techniques and lens customization.


Segment Analysis


The Global Intraocular Lens Market is segmented by Product Type, Material Type, Surgery Type, and End Use.


By Product Type, the market includes Monofocal, Multifocal, Toric, and Accommodating lenses. Monofocal lenses dominate the market, valued at 2.32 USD Billion in 2024, and are expected to reach 3.5 USD Billion by 2035, due to their affordability and effectiveness in restoring clear vision at a single distance. Multifocal lenses, valued at 1.32 USD Billion in 2024 and projected to expand to 2.0 USD Billion by 2035, are increasingly popular for providing vision correction across multiple distances. The Toric lens segment, valued at 0.8 USD Billion in 2024 and forecasted to rise to 1.2 USD billion by 2035, is gaining traction owing to its capability to correct astigmatism. Accommodating lenses, though niche, are valued at 0.2 USD Billion in 2024 and expected to reach 0.5 USD Billion by 2035, reflecting technological innovation focused on mimicking the eye’s natural accommodation.


By Material Type, the market comprises Acrylic, Silicone, PMMA, and Hydrophilic lenses. Acrylic materials, known for their biocompatibility, dominate the segment, while Silicone lenses are valued for their flexibility and comfort. PMMA lenses continue to be used, particularly in developing regions, due to their proven reliability. Hydrophilic lenses are witnessing growing demand due to their moisture-retention properties that enhance patient comfort post-surgery.


Based on Surgery Type, the market includes Phacoemulsification, Extracapsular Cataract Surgery, and Intracapsular Cataract Surgery. Phacoemulsification remains the most preferred technique globally due to its minimally invasive nature and rapid recovery outcomes. Extracapsular Cataract Surgery retains significance in complex cases, while Intracapsular Cataract Surgery continues to be used selectively for advanced cataract conditions.


By End Use, the market is segmented into Hospitals, Eye Clinics, and Ambulatory Surgical Centers. Hospitals dominate due to their advanced infrastructure and comprehensive ophthalmic care capabilities. Eye Clinics play an essential role in personalized eye care, while Ambulatory Surgical Centers are increasingly preferred for their cost-effectiveness and convenience. Together, these end-use sectors highlight the expanding accessibility and patient-centric approach driving the global intraocular lens industry.


Regional Analysis


Regionally, the Global Intraocular Lens Market shows strong growth across North America, Europe, Asia Pacific, South America, and the Middle East & Africa. North America leads the market, valued at 1.55 USD Billion in 2024 and expected to reach 2.43 USD Billion by 2035, driven by advanced healthcare systems and strong investments in ophthalmic technology. Europe follows closely, with a valuation of 1.25 USD Billion in 2024 projected to reach 1.92 USD Billion by 2035, supported by high adoption of modern lens technologies and favorable reimbursement structures.


Asia Pacific, valued at 1.35 USD Billion in 2024 and forecasted to reach 2.08 USD Billion by 2035, is emerging as a high-growth region due to its expanding elderly population, increasing cataract prevalence, and improved healthcare infrastructure. South America and the Middle East & Africa, valued at 0.28 USD Billion and 0.21 USD Billion, respectively, in 2024, are expected to reach 0.43 USD Billion and 0.34 USD Billion by 2035, benefiting from growing investments in healthcare and broader access to surgical services.


Regional growth patterns indicate a global convergence toward advanced ophthalmic technologies and greater awareness of vision correction solutions, ensuring sustained momentum across both developed and developing economies.


Key Findings of the Study



  • The Global Intraocular Lens Market is projected to grow from USD 5.32 billion in 2025 to USD 9.28 billion by 2035, at a CAGR of 5.72%.

  • The market was valued at 5.03 USD Billion in 2024.

  • Monofocal lenses dominate the product type segment, followed by Multifocal, Toric, and Accommodating lenses.

  • Acrylic remains the most widely used material, with Hydrophilic materials gaining traction.

  • Phacoemulsification is the preferred surgical technique due to its efficiency and minimal invasiveness.

  • Hospitals lead the end-use segment, with Eye Clinics and Ambulatory Surgical Centers showing increasing adoption.

  • North America holds the largest market share, followed by Europe and the Asia Pacific, with the latter anticipated to experience robust growth.

  • Key market drivers include the aging population, rising cataract surgeries, and continuous technological innovation in lens design.